Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Ahmed Elkhanany
Assistant Professor
Close
E-mail
elky@uab.edu
aelkhanany@uabmc.edu
Phone
205-934-7825
Links
Provider Directory
LinkedIn
Personal
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Ahmed Elkhanany
Assistant Professor
Positions
Associate Scientist
,
Experimental Therapeutics
,
O'Neal Comprehensive Cancer Center
Associate Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
2019 -
Assistant Professor (P)
,
Medicine - Hematology & Oncology
,
Department of Medicine
2019 -
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2021
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T Cell Exhaustion.
2021
2021
Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2021
2021
2020
Contribution of immune cells to glucocorticoid receptor expression in breast cancer
.
International Journal of Molecular Sciences
. 21:1-17.
2020
2020
Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 1.2020 featured updates to the NCCN guidelines
2020
2019
Primary and secondary breast angiosarcoma: single center report and a meta-analysis
.
Breast Cancer Research and Treatment
. 178:523-533.
2019
2018
Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer
.
Breast Cancer Research and Treatment
. 167:89-99.
2018
2015
Clinical correlates of common corneal neovascular diseases: A literature review
.
International Journal of Ophthalmology
. 8:182-193.
2015
2015
Cocaine induced pleural and pericardial effusion syndrome.
2015
2014
GAIP interacting protein C-Terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways
.
PLoS ONE
. 9.
2014
2013
Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo
.
International Journal of Cancer
. 132:1201-1212.
2013
Research
Principal Investigator On
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
2019 - 2027
Private Grant
awarded by
TRANSLATIONAL BREAST CANCER RESEARCH CONSORTIUM
2020 - 2025
TBCRC -AURORA US: A Prospective Biospecimen Repository in Metastic Breast Cancer
awarded by
Johns Hopkins University
2020 - 2025
Private Grant
awarded by
SERMONIX PHARMACEUTICALS INC
2021 - 2024
Private Grant
awarded by
Pfizer Inc., U.S. Pharmaceuticals Group
2021 - 2024
Investigator On
ECOG-ACRIN Purchase Service Agreement
awarded by
Eastern Cooperative Oncology Group
2019 - 2024
Private Grant
awarded by
SEATTLE GENETICS, INC.
2020 - 2023
FDG PET to Assess Therapeutic Response in Patients with Bone-Dominant Metastatic Breast Cancer, FEATURE R20-080
awarded by
ECOG-ACRIN CANCER RESEARCH GROUP
2020 - 2023
UAB 17127-A Phase 1b Trial of Fulvestrant, Palbociclib (CDK4/6 inhibitor) and Erdafitinib (JNJ-42756493, Pan-FGFR Tyrosine Kinase Inhibitor) in ER+/HER2–/FGFR-Amplified Metastatic Breast Cancer (MBC)
awarded by
VANDERBILT UNIVERSITY
2019 - 2023
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
2019 - 2022
UAB 1174: Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis 2
awarded by
QUANTUM LEAP HEALTH CARE
2018 - 2021
Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect
awarded by
University of Wisconsin-Madison
2016 - 2021
UAB 1428 – A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer (HOG Trial)
awarded by
HOOSIER CANCER RESEARCH NETWORK
2019 - 2020
Private Grant
awarded by
Pfizer Pharmaceuticals
2019 - 2020
Background
Education And Training
Doctor of Medicine,
Alexandria University
2011
Contact
Full Name
Ahmed
Elkhanany
